Table 6.
Reference scenario (standard of care) | New scenario (epigenetic assay) | |||
---|---|---|---|---|
Cost | Total annual cost, $ | PMPM cost, $ | Total annual cost, $ | PMPM cost, $ |
Total cost of epigenetic assay | 0 | 0.00 | 5,346,168 | 0.53 |
Total cost of repeated biopsies | 9,429,097 | 1.09 | 2,342,681 | 0.27 |
Total cost of repeated biopsies avoided | 0 | 0.00 | 7,086,416 | 0.82 |
Total diagnostic cost to health plan | 9,429,097 | 1.09 | 7,688,849 | 0.81 |
Total diagnostic cost per patient | 3172 | 0.33 | 2584 | 0.24 |
Total budget impact to plan | −1,740,248 | |||
Total budget impact to plan PMPM | −0.1450 |
PMPM indicates per member per month.